Search

Your search keyword '"Wei-Hsian Yin"' showing total 219 results

Search Constraints

Start Over You searched for: Author "Wei-Hsian Yin" Remove constraint Author: "Wei-Hsian Yin" Database OpenAIRE Remove constraint Database: OpenAIRE
219 results on '"Wei-Hsian Yin"'

Search Results

3. The clinical significance of osteopontin on the cardiovascular outcomes in patients with stable coronary artery disease

4. Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study

5. Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial

6. 2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes

8. The safety and efficacy of the Mo.Ma system device for carotid artery stenting: A single-center experience from Taiwan

9. Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy

10. Utilization of two- and three-dimensional transesophageal echocardiography in successfully guiding transcatheter mitral valve in bioprosthetic mitral valve/mitral ring implantation without complications in patients with thrombus in left atrium/left atrial appendage

11. The prognostic significance of the presence of tenascin-C in patients with stable coronary heart disease

12. Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization

13. The Presence of Calcified Raphe Is an Independent Predictor of Adverse Long-Term Clinical Outcomes in Patients With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

14. Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment

15. Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease

16. Computed Tomography-Determined Muscle Quality Rather Than Muscle Quantity Is a Better Determinant of Prolonged Hospital Length of Stay in Patients Undergoing Transcatheter Aortic Valve Implantation

17. Recovery of left ventricular dysfunction after sacubitril/valsartan: predictors and management

18. Prescription patterns of diabetes medications influencing clinical outcomes of heart failure patients with reduced ejection fraction

19. A HANC Risk Stratification Score for Antiplatelet Therapy Optimization with Low-Dose Prasugrel in Taiwanese Acute Coronary Syndrome Patients from the Switch Study

20. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

21. Outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation with the use of newer- vs. early-generation devices

22. Electrocardiography Score for Left Ventricular Systolic Dysfunction in Non-ST Segment Elevation Acute Coronary Syndrome

23. Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan

24. TCT-549 Impact of COVID-19 Pandemic on TAVR Activity: A Worldwide Registry

25. The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure

26. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

27. Percutaneous Coronary Intervention for Very Small Vessels With the Use of a Newer-Generation 2.0 mm Drug-Eluting Stent

28. Fenofibrate Reverses Dysfunction of EPCs Caused by Chronic Heart Failure

29. Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation

30. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease

31. Impact of type D personality on clinical outcomes in Asian patients with stable coronary artery disease

32. The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention

33. Factors Associated With the Utilization of Outpatient Virtual Clinics: Retrospective Observational Study Using Multilevel Analysis

34. Endothelin-1 induces lipolysis through activation of the GC/cGMP/Ca

35. Effects of Transapical Transcatheter Mitral Valve Implantation

36. Sex differences in patients undergoing transcatheter aortic valve replacement in Asia

37. The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease

38. Adherence to Healthy Lifestyle Improved Clinical Outcomes in Coronary Artery Disease Patients After Coronary Intervention

39. Fenofibrate attenuates doxorubicin-induced cardiac dysfunction in mice via activating the eNOS/EPC pathway

40. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation. the GLORIA-AF registry

41. 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases

42. Stepwise manipulation of cardiac computed tomography multi-planar reconstruction to mimic transesophageal echocardiography

43. Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial

44. Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease

46. Endothelin-1 induces lipolysis through activation of the GC/cGMP/Ca2+/ERK/CaMKIII pathway in 3T3-L1 adipocytes

47. On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study

48. Correction to: Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy

49. When high-volume PCI operators in high-volume hospitals move to lower volume hospitals-Do they still maintain high volume and quality of outcomes?

50. Trends in proportions of hospitals and operators not meeting minimum percutaneous coronary intervention volume standards in Taiwan, 2001-2013

Catalog

Books, media, physical & digital resources